Skip to main content

Update in Melanoma in Organ Transplant Patients

  • Chapter
  • First Online:
Advances in Transplant Dermatology

Abstract

There are three major categories of transplant melanoma: pretransplant, posttransplant, and donor-derived melanoma. Dermatologists are involved in screening transplant candidates to help identify a history of pretransplant melanoma or other high-risk factors for posttransplant melanoma. For those with a history of pretransplant melanoma, AJCC melanoma staging should help guide wait times prior to transplantation to ensure ethical allocation of a scarce resource. The incidence of posttransplant malignant melanoma is estimated to be three to five times higher than the general public and is associated with a worse prognosis. While donor-derived melanoma is rare in transplant patients, it has been reported as the most commonly transmitted tumor-causing distant metastasis and is associated with a poor overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AJCC:

American Joint Committee on Cancer

AKs:

Actinic keratosis

FISH:

Fluorescent in situ hybridization

HLA:

Human leukocyte antigen

IHC:

Immunohistochemistry

ITSC:

International Transplant Skin Cancer Collaborative

NCCN:

National Comprehensive Cancer Network

NIH:

National Institutes of Health

NMSC:

Nonmelanoma skin cancer

OPTN:

Organ Procurement and Transplantation Network

OTRs:

Organ transplant recipients

PCR:

Polymerase chain reaction

SCOPE:

Skin Care in Organ Transplant Patients, Europe

SRTR:

Scientific Registry of Transplant Recipients

USA:

United States of America

References

  1. Ali FR, Lear JT. Melanoma in organ transplant recipients: incidence, outcomes, and management considerations. J Skin Cancer. 2012, epub.

    Google Scholar 

  2. Bajaj NS, Watt C, Hadjiliadis D, et al. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int. 2010;23(7):e26–31.

    Article  PubMed  Google Scholar 

  3. Berg, Otley. The reference is Skin cancer in organ transplant recipients. Epidemiology, pathogenesis and management. J Am Acad Dermatol. 2002;47(1):1–17.

    Google Scholar 

  4. Birkeland SA, Storm HH. Risks for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation. 2002;74:1409–13.

    Article  PubMed  Google Scholar 

  5. Brewer JD, Christenson LJ, Weaver AL, et al. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol. 2011;147(7):790–6.

    Article  PubMed  Google Scholar 

  6. Chen KT, Olszanski A, Farma JM. Donor transmission of melanoma following renal transplant. Case Rep Transplant epub 2012. http://dx.doi.org/10.1155/2012/764019.

  7. Colegio OR, Proby CM, Bordeaux JS, McGregor JM, Melanoma Working Group of the International Transplant Skin Cancer C, Skin Care in Organ Transplant Patients E. Prognosis of pretransplant melanoma. Am J Transplant. 2009;9(4):862.

    Article  CAS  PubMed  Google Scholar 

  8. Dapprich DC, Weenig RH, Rohlinger AL, Weaver AL, et al. Outcomes of melanoma in recipients of solid organ transplantation. J Am Acad Dermatol. 2008;59:405–17.

    Article  PubMed  Google Scholar 

  9. Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, et al. Spectrum of cancer risk among US solid organ transplant recipients: the transplant cancer match study. JAMA. 2011;306(17):1891–901.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681–91.

    Article  PubMed  Google Scholar 

  11. Hartevelt MM, Bavenick JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49:506–9.

    Google Scholar 

  12. Hollenbeak CS, Todd MM, Billingsley EM, et al. Increased incidence of melanoma in renal transplant recipients. Cancer. 2004;104:1962–7.

    Google Scholar 

  13. Ismail F, Mitchell L, Casabonne D, et al. Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. Br J Dermatol. 2006;155:916–25.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Jensen P, Hansen S, Moller B, Leivestad T, Pfefer P, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177–86.

    Article  CAS  PubMed  Google Scholar 

  15. Le Mire L, Hollowood K, Gray D, et al. Melanomas in renal transplant recipients. Br J Dermatol. 2006;154(3):472–7.

    Article  PubMed  Google Scholar 

  16. Martin DC, Rubini M, Rosen VJ. Cadaveric renal homotransplantations with inadvertent transplantation of cancer. JAMA. 1965;192:32.

    Article  Google Scholar 

  17. Matin RN, Mesher D, Proby CM, McGregor JM, et al. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant. 2008;8:1891–900.

    Article  CAS  PubMed  Google Scholar 

  18. McCarter MD, Baumgartner J, Escobar GA, et al. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients. Ann Surg Oncol. 2007;14(10):2854–60.

    Article  PubMed  Google Scholar 

  19. Mihalis EL, Wysong A, Boscardin WJ, et al. Factors affecting sunscreen use and sun avoidance in a US national sample of organ transplant recipients. Br J Dermatol. 2013;168(2):346–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Morris-Stiff G, Steel A, Savage P, Devlin J, et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant. 2004;4:444–6.

    Article  CAS  PubMed  Google Scholar 

  21. Multigonda T, Levender MM, O’Neill JL, West CE, et al. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single and multicenter retrospective studies from 2006 to 2010. Dermatol Surg. 2013;39:345–64.

    Article  Google Scholar 

  22. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: OPTN/SRTR 2011 Annual Data Report. Rockville: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2012.

    Google Scholar 

  23. Otley CC, Berg D, Ulrich C, et al. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol. 2006;154(3):395–400.

    Article  CAS  PubMed  Google Scholar 

  24. Penn I. Malignant melanoma in organ allograft recipients. Transplantation. 1996;61:274–8.

    Article  CAS  PubMed  Google Scholar 

  25. Scanlon EF, Hawkins RA, Fox WW, Smith WS. Fatal homotransplanted melanoma: a case report. Cancer. 1965;13:782–9.

    Article  Google Scholar 

  26. Servilla KS, Burnham DK, Daynes RA. Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice. Transplantation. 1987;44:291–5.

    Article  CAS  PubMed  Google Scholar 

  27. Sheil AG. Development of malignancy following renal transplantation in Australia and New Zealand. Transplant Proc. 1992;24:1275–9.

    CAS  PubMed  Google Scholar 

  28. Suranyi MG, Hogan PG, Falk MC, et al. Advanced donor-origin melanoma in a renal transplant patient. Transplantation. 1998;66:655.

    Article  CAS  PubMed  Google Scholar 

  29. Viguier M, Lemaitre F, Verola O, et al. Foxp3 expressing CD4 + CD25+ regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol. 2004;173(2):1444–53.

    Article  CAS  PubMed  Google Scholar 

  30. Wilson RN, Hager EB, Hampers CL, et al. Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med. 1968;278:479.

    Article  CAS  PubMed  Google Scholar 

  31. Younis FM, Fernando ON, Sweny P, et al. Malignant melanoma in a patient with a renal transplant. Lancet. 1980;2:1141.

    Article  CAS  PubMed  Google Scholar 

  32. Zwald FO, Christenson LJ, Billingsley EM, et al. Melanoma in solid organ transplant recipients. Am J Transplant. 2010;10(5):1297–304.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seaver L. Soon MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Wysong, A., Soon, S.L. (2015). Update in Melanoma in Organ Transplant Patients. In: Zwald, F., Brown, M. (eds) Advances in Transplant Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-12445-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12445-2_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-12444-5

  • Online ISBN: 978-3-319-12445-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics